Morishima Yasuo | Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital
スポンサーリンク
概要
Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital | 論文
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study